Data from epgonline.org - Curated by EPG Health - Date added 22 March 2019

The International Liver Congress (ILC) takes place in Vienna, Austria from 10th - 14th April 2019.

The ILC attracts around 10,000 delegates and 250 media representatives from all over the world. Medical experts from a range of fields come together to learn about the latest in liver research.

Some of the ICL 2019 scientific program includes

  • Basic science highlights
  • Basic science seminar: Liver immunology and immunotherapy
  • Breakfast morning rounds
  • Critical reflections on landmark papers*
  • Grand rounds*
  • Meet the experts
  • Postgraduate course: End-stage liver disease

Further details can be found on the ILC 2019 website here.

Comments

You will need to login, to leave a comment.

epgonline.org is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

CDK 4/6 inhibitors in metastatic breast cancer

CDK 4/6 inhibitors in metastatic breast cancer

The CDK 4/6 Inhibitors in Metastatic Breast Cancer Learning Zone provides insights and information for metastatic breast cancer (mBC) and CDK 4/6 signalling. This includes the burden and pathophysiology of the disease, the role of CDK 4/6 in cell proliferation and an overview of the CDK 4/6 inhibitors that have been approved for the management of mBC.

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more

Biosimilars in Oncology Knowledge Centre

Biosimilars in Oncology Knowledge Centre

What are biologics and how do they differ from small molecule medicines? Discover more about their development, as well as the manufacturing and regulatory processes in the Biosimilars in Oncology Knowledge Centre.

Load more

Related Content